IVIg is generated from the pooled immunoglobulin G of approximately one thousand blood donors and could be used for treating coronavirus, says GlobalData.
First COVID-19 Patient Recovers Well After Administration of Plasma Therapy
First COVID-19 patient who was administered Plasma Therapy at Max Hospital, Delhi, has shown positive results and was recently weaned off ventilator support.
First COVID-19 patient who was administered Plasma Therapy at Max Hospital, Delhi, has shown positive results and was recently weaned off ventilator support.
‘COVID-19: Some small studies have shown that early treatment with IVIg (intravenous immunoglobulin), within 48 hours of admission, can help reduce ventilator use, reduce hospital and intensive care unit stay, and improve mortality.’
These donors could be recovered or asymptomatic COVID-19 patients. Recovered patients only have to wait 28 days before they are cleared for donating. IVIg differs from recovered patient antibodies in that there is no guarantee that the pooling contains COVID-19-specific antibodies.” Hospitals already have IVIg in stock. It has already been approved for treating autoimmune, infectious, idiopathic diseases, and is used as an adjunctive therapy for the treatment of severe pneumonia caused by influenza. It has a known safety profile and can be administered intravenously in a hospital setting.
The timing of the administration may be a critical part of this treatment, as patients may need to be assessed for their likelihood of developing severe COVID-19. IVIg treatment is also expensive, with cost ranging from $4,000 to $10,000 depending on the patient's weight and number of infusions per course.
Coronavirus
Coronaviruses infect animals, humans, and birds. Human coronaviruses, such as SARS, MERS, and 2019-nCoV cause respiratory distress and even death. The S protein is the infectious agent of the virus.
Coronaviruses infect animals, humans, and birds. Human coronaviruses, such as SARS, MERS, and 2019-nCoV cause respiratory distress and even death. The S protein is the infectious agent of the virus.
Source-Medindia
ICMR Nod to New Antigen Test for Coronavirus Detection
The Indian Council of Medical Research (ICMR) on Tuesday recommended newer additional strategies for COVID-19 testing, as it allowed the use of an antigen test to fast-track testing and tracing of positive cases.
The Indian Council of Medical Research (ICMR) on Tuesday recommended newer additional strategies for COVID-19 testing, as it allowed the use of an antigen test to fast-track testing and tracing of positive cases.
Novel COVID-19 Accelerometer can Measure Prevalence of Coronavirus in Real-time
New computational tool that acts like a COVID-19 accelerometer shows in real-time the rate at which coronavirus growth is accelerating or decelerating in over 200 countries and territories.
New computational tool that acts like a COVID-19 accelerometer shows in real-time the rate at which coronavirus growth is accelerating or decelerating in over 200 countries and territories.
